Marshall Wace LLP Buys Shares of 71,636 National Research Co. (NASDAQ:NRC)

Marshall Wace LLP bought a new stake in National Research Co. (NASDAQ:NRC - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 71,636 shares of the company's stock, valued at approximately $1,644,000. Marshall Wace LLP owned about 0.30% of National Research at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Norden Group LLC bought a new stake in shares of National Research in the 1st quarter valued at about $5,170,000. Renaissance Technologies LLC raised its holdings in National Research by 14.4% in the second quarter. Renaissance Technologies LLC now owns 432,884 shares of the company's stock worth $9,935,000 after purchasing an additional 54,600 shares during the period. US Bancorp DE boosted its position in shares of National Research by 85.3% during the first quarter. US Bancorp DE now owns 47,242 shares of the company's stock worth $1,871,000 after purchasing an additional 21,750 shares in the last quarter. Sei Investments Co. boosted its position in shares of National Research by 45.2% during the first quarter. Sei Investments Co. now owns 61,770 shares of the company's stock worth $2,447,000 after purchasing an additional 19,217 shares in the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of National Research by 0.6% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,045,306 shares of the company's stock valued at $69,890,000 after buying an additional 18,891 shares during the period. Institutional investors and hedge funds own 47.26% of the company's stock.

National Research Trading Down 1.4 %

National Research stock traded down $0.28 during mid-day trading on Friday, hitting $19.97. 62,010 shares of the company's stock were exchanged, compared to its average volume of 87,901. National Research Co. has a fifty-two week low of $19.92 and a fifty-two week high of $46.87. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $476.82 million, a P/E ratio of 16.10 and a beta of 0.49. The company's 50 day simple moving average is $22.05 and its 200-day simple moving average is $27.21.

National Research (NASDAQ:NRC - Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.26 EPS for the quarter. National Research had a return on equity of 63.64% and a net margin of 20.01%. The company had revenue of $35.02 million for the quarter.

National Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date is Friday, September 27th. National Research's payout ratio is currently 38.71%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.